Sight Sciences (NASDAQ:SGHT – Get Free Report) posted its earnings results on Thursday. The company reported ($0.22) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.35) by $0.13, Zacks reports. Sight Sciences had a negative return on equity of 40.69% and a negative net margin of 68.53%. The business had revenue […]
Sight Sciences (NASDAQ:SGHT – Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.22) EPS for the quarter, beating analysts’ consensus estimates of ($0.35) by $0.13, Zacks reports. Sight Sciences had a negative return on equity of 40.69% and a negative net margin of 68.53%. The firm had revenue of $18.75 […]
Contrasting Sight Sciences (NASDAQ:SGHT) & Profound Medical (NASDAQ:PROF) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
MENLO PARK, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative,
Sight Sciences Announces European Launch of the Ergo-Series of the OMNI® Surgical System at the ESCRS Winter Meeting forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.